HOT PRODUCT | LOW STOCK
BODY PHARM Cagrisema 12mg Pen™
BODY PHARM Cagrisema 12mg Pen™
✨ Premium quality you can trust
🧬 Science inspired performance essentials
🚚 Fast, secure nationwide delivery
BUNDLE & SAVE
Couldn't load pickup availability
customer checkout trust
BODY PHARM Cagrisema 12mg Pen™
Get it in 5-8 working days
Cagrisema 12mg Pen™
Meet the Cagrisema 12mg Pen™ — a cutting-edge, pre-filled peptide pen delivering a precise 12mg dose of Cagrisema. This dual-acting GLP-1 and amylin receptor agonist combination is designed for metabolic and weight management research.
What is Cagrisema?
Cagrisema is an investigational combination of Cagrilintide, a long-acting amylin analogue, and Semaglutide, a GLP-1 receptor agonist. Together, they work on complementary pathways linked to appetite regulation, glucose metabolism and body weight management research.
Appetite Regulation
Dual-pathway action targets hunger signals for appetite-control research.
Weight Management
Studied for body weight management and metabolic support research.
Glucose Metabolism
Associated with healthy blood sugar regulation and insulin sensitivity pathways.
Cardiometabolic Support
GLP-1 agonism is associated with improved cardiometabolic marker research.
Sustained Action
Long-acting fortion designed for consistent weekly dosing research.
Why the 12mg Pen?
Ready-to-Use Format
Pre-filled with 12mg of Cagrisema for accurate, repeatable dosing. The intuitive pen design is made for convenience, consistency and easy handling.
For research and informational purposes only. Always consult a qualified healthcare professional before use.
product benefits
Research Grade Quality
Premium peptide products prepared for controlled research and professional use.
Precision Formulation
Carefully measured concentrations designed to support consistency and accuracy.
Secure Product Integrity
Packaged and handled with care to help maintain quality from dispatch to delivery.
Comparison table
Talk about how and why is your brand better than the others.
| EnduroFlow | OTHERS | |
|---|---|---|
Benefit |
||
Benefit |
||
Benefit |
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER